Discovery of Novel Biomarkers of Therapeutic Responses in Han Chinese Pemetrexed-Based Treated Advanced NSCLC Patients

• Main Authors: Xiaoqing Zhang (Author), Di Zhang (Author), Lihua Huang (Author), Guorong Li (Author), Luan Chen (Author), Jingsong Ma (Author), Mo Li (Author), Muyun Wei (Author), Wei Zhou (Author), Chenxi Zhou (Author), Jinhang Zhu (Author), Zhanhui Wang (Author), Shengying Qin (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Pemetrexed, one of the most commonly used drugs in advanced non-small cell lung cancer (NSCLC) therapies, often leads to various therapeutic responses in patients. These therapeutic responses to pemetrexed, including adverse drug reactions (ADRs) and its intended therapeutic effects, have been demon...